Comparison of praziquantel, amoscanate and hexachloroparaxylol in clonorchiasis sinensis.
D000293:Adolescent; D000328:Adult; D000814:Aniline Compounds / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003003:Clonorchiasis / Q000188:drug therapy*; D003004:Clonorchis sinensis / Q000187:drug effects; D004159:Diphenylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D017879:Isothiocyanates; D008297:Male; D010270:Parasite Egg Count; D011223:Praziquantel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013861:Thiocyanates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014992:Xylenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000814:Aniline Compounds; D007546:Isoquinolines; D017879:Isothiocyanates; D013861:Thiocyanates; D014992:Xylenes; D011223:Praziquantel; C000294:hexachloro-4-xylene; D004159:Diphenylamine; C012391:amoscanate